These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15454221)

  • 41. C3'-cis-Substituted carboxycyclopropyl glycines as metabotropic glutamate 2/3 receptor agonists: synthesis and SAR studies.
    González R; Collado I; de Uralde BL; Marcos A; Martín-Cabrejas LM; Pedregal C; Blanco-Urgoiti J; Pérez-Castells J; Fernández MA; Andis SL; Johnson BG; Wright RA; Schoepp DD; Monn JA
    Bioorg Med Chem; 2005 Dec; 13(23):6556-70. PubMed ID: 16153851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
    Kew JN
    Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2).
    Rudd MT; McCauley JA
    Curr Top Med Chem; 2005; 5(9):869-84. PubMed ID: 16178732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.
    Iacovelli L; Molinaro G; Battaglia G; Motolese M; Di Menna L; Alfiero M; Blahos J; Matrisciano F; Corsi M; Corti C; Bruno V; De Blasi A; Nicoletti F
    Mol Pharmacol; 2009 Apr; 75(4):991-1003. PubMed ID: 19164443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of functionalized acetophenones as protein tyrosine phosphatase 1B inhibitors.
    Dixit M; Tripathi BK; Srivastava AK; Goel A
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3394-7. PubMed ID: 15951172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positive and negative modulation of group I metabotropic glutamate receptors.
    Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
    J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
    Vogensen SB; Frydenvang K; Greenwood JR; Postorino G; Nielsen B; Pickering DS; Ebert B; Bølcho U; Egebjerg J; Gajhede M; Kastrup JS; Johansen TN; Clausen RP; Krogsgaard-Larsen P
    J Med Chem; 2007 May; 50(10):2408-14. PubMed ID: 17455929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.
    D'Alessandro PL; Corti C; Roth A; Ugolini A; Sava A; Montanari D; Bianchi F; Garland SL; Powney B; Koppe EL; Rocheville M; Osborne G; Perez P; de la Fuente J; De Los Frailes M; Smith PW; Branch C; Nash D; Watson SP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):759-62. PubMed ID: 20005096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organocatalytic enantioselective synthesis of metabotropic glutamate receptor ligands.
    Suri JT; Steiner DD; Barbas CF
    Org Lett; 2005 Sep; 7(18):3885-8. PubMed ID: 16119923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.
    Homayoun H; Jackson ME; Moghaddam B
    J Neurophysiol; 2005 Apr; 93(4):1989-2001. PubMed ID: 15590730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
    Noeske T; Jirgensons A; Starchenkovs I; Renner S; Jaunzeme I; Trifanova D; Hechenberger M; Bauer T; Kauss V; Parsons CG; Schneider G; Weil T
    ChemMedChem; 2007 Dec; 2(12):1763-73. PubMed ID: 17868161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
    Vogensen SB; Clausen RP; Greenwood JR; Johansen TN; Pickering DS; Nielsen B; Ebert B; Krogsgaard-Larsen P
    J Med Chem; 2005 May; 48(9):3438-42. PubMed ID: 15857151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.
    Cid JM; Duvey G; Tresadern G; Nhem V; Furnari R; Cluzeau P; Vega JA; de Lucas AI; Matesanz E; Alonso JM; Linares ML; Andrés JI; Poli SM; Lutjens R; Himogai H; Rocher JP; Macdonald GJ; Oehlrich D; Lavreysen H; Ahnaou A; Drinkenburg W; Mackie C; Trabanco AA
    J Med Chem; 2012 Mar; 55(5):2388-405. PubMed ID: 22364337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists.
    Galatsis P; Yamagata K; Wendt JA; Connolly CJ; Mickelson JW; Milbank JB; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6525-8. PubMed ID: 17936624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.